EUCTR2009-010952-81-GB进行中（未招募）不适用
The use of Metformin and Gonadotrophin Releasing Hormone Antagonist for the treatment of women with Polycystic Ovary Syndrome undergoing In-vitro Fertilisation-Embryo Transfer. - Metformin and GnRH Antagonist co-treatment in IVF for women with PCOS
eeds Teaching Hospitals NHS Trust0 个研究点开始时间: 2009年7月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women who will be invited to take part in this study would be subject to following inclusion criteria: •Women with a known diagnosis of PCOS (as defined by the Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group, 2004) •Women must have a normal follicular stimulating hormone (FSH) •Women must be 20-39 years of age •Women must have a BMI = 35 •Pre-treatment inclusion criteria would include: oSerum testosterone < 5.0 nmol/l oNormal prolactin oNormal thyroid function tests oNormal renal, liver & haematological indices
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Women who do not conform to the above criteria would be excluded from the study In addition to the above these specific exclusion criteria would apply: •Women on other oral-antidiabetic agents or blood-glucose lowering preparations. •Women taking phenprocoumon •Women taking antivirals such as didanosine, stavudine, tenofovir. •Women taking cimetidine •Women taking ketofen •Women who have radiological examinations using contrast media within the preceding 48 hours. •Women with renal or hepatic impairment •Women who have had a recent myocardial infarct •Women with known vitamin B12 deficiency
研究者
相似试验
已完成
4 期
Metformin and gonadotrophin-releasing hormone (GnRH) antagonist co-treatment in in-vitro fertilisation (IVF) for women with polycystic ovary syndrome (PCOS)Polycystic ovary syndromeNutritional, Metabolic, EndocrineOvarian dysfunctionISRCTN21199799eeds Teaching Hospitals NHS Trust (UK)200
进行中（未招募）
不适用
The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. - Metformin in frozen embryo replacement cycles in women with PCOSPolycystic Ovary SyndromeEUCTR2009-017245-64-GBeeds Teaching Hospitals NHS Trust140
已完成
不适用
Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitusNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusType 1 diabetesISRCTN51650949Scientific and Technological Development Fund (FONDECYT Fondo de Desarrollo Científico y Tecnológico) (Chile)24
尚未招募
1 期
Metabolism Prescription Combined with Metformin in the Intervention of Type 2 Diabetes Mellitus Combined with Obesity: a Multicenter Randomized Controlled Double-Blind Clinical StudyType 2 Diabetes Mellitus combined with ObesityITMCTR2000003636onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
已完成
2 期
Gastrointestinal mechanisms underlying glucose lowering by metformin in type 2 diabetesType 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12617000243314niversity of Adelaide10